Key result
Acute MI fails to alter serum 25(OH)D levels across a 90-day observation period.
Why the study?
There is uncertainty whether serum 25 hydroxy-vitamin D concentrations exhibit an acute phase reaction after acute myocardial infarction affecting its reliability as a vitamin D status marker.
Observational (n=32)
Answers are grounded in this paper and cite their sources.
25(OH)D remains stable post-MI; supports reliable acute measurement but leaves open independent prognostic value.
BACKGROUND: There is growing epidemiological evidence linking serum 25 hydroxy-vitamin D (25(OH)D) concentrations to outcome in cardiovascular and other diseases. We have studied patients with acute myocardial infarction (AMI) to determine if they exhibit an acute phase reaction affecting 25(OH)D. METHODS: Patients (n=32) with first AMI who had been treated with primary percutaneous coronary intervention within 12 h of symptom onset had venous blood samples taken two days, one week, one month and three months after presentation. Samples were analysed for troponin I, C-reactive protein (CRP) and 25(OH)D. RESULTS: All patients had significant rises in troponin confirming the myocardial damage and CRP, both of which resolved by 28 days. In contrast, 25(OH)D remained unchanged throughout the 90-day observation period with a median concentration of 46 nmol/L. CONCLUSION: Serum 25(OH)D does not change after AMI and is likely to be a reliable marker of vitamin D status in patients with cardiovascular disease.
No takes yet. Share an insight, caveat, or question.
Barth et al. (2012) conducted an observational in Acute myocardial infarction (n=32). Acute myocardial infarction was evaluated on Change in serum 25 hydroxy-vitamin D (25(OH)D) concentrations. Acute myocardial infarction did not induce an acute phase reaction affecting serum 25(OH)D, which remained unchanged throughout a 90-day observation period with a median concentration of 46 nmol/L.
Synapse has enriched 10 related papers. Consider them for comparative context: